Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Immuneering (IMRX) Other Operating Expenses (2022 - 2024)

Immuneering (IMRX) has 4 years of Other Operating Expenses data on record, last reported at $7317.0 in Q4 2024.

  • For Q4 2024, Other Operating Expenses changed 0.0% year-over-year to $7317.0; the TTM value through Dec 2024 reached $29267.0, changed 0.0%, while the annual FY2024 figure was $29267.0, 0.0% changed from the prior year.
  • Other Operating Expenses reached $7317.0 in Q4 2024 per IMRX's latest filing, roughly flat from $7317.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $3.9 million in Q2 2020 and bottomed at $7316.0 in Q4 2022.
  • Average Other Operating Expenses over 4 years is $302999.3, with a median of $7317.0 recorded in 2022.
  • The widest YoY moves for Other Operating Expenses: up 0.01% in 2023, down 9.7% in 2023.
  • A 4-year view of Other Operating Expenses shows it stood at $3.9 million in 2020, then crashed by 99.81% to $7316.0 in 2022, then grew by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $7317.0 in Q4 2024, $7317.0 in Q3 2024, and $7316.0 in Q2 2024.